Phillip M. Gerk

1.5k total citations
53 papers, 1.2k citations indexed

About

Phillip M. Gerk is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Phillip M. Gerk has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Phillip M. Gerk's work include Drug Transport and Resistance Mechanisms (19 papers), Pregnancy and Medication Impact (7 papers) and Pregnancy and preeclampsia studies (6 papers). Phillip M. Gerk is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), Pregnancy and Medication Impact (7 papers) and Pregnancy and preeclampsia studies (6 papers). Phillip M. Gerk collaborates with scholars based in United States, China and Chile. Phillip M. Gerk's co-authors include Mary Vore, Soniya Vaidya, Patrick J. McNamara, Abhishek Gulati, Amal Akour, Mary Jayne Kennedy, Zhenxian Zhang, Nirmala S. Desai, Robert J. Kuhn and Jeffrey A. Moscow and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Controlled Release.

In The Last Decade

Phillip M. Gerk

51 papers receiving 1.1k citations

Peers

Phillip M. Gerk
Rajgopal Govindarajan United States
Justina C. Calamia United States
Dandan Wang China
Diane R. Umbenhauer United States
Pavol Žúbor Slovakia
Kamil Biringer Slovakia
Leslie J. Dickmann United States
Elodie Jouan France
María Laura Ruiz Argentina
Samaisukh Sophasan Thailand
Rajgopal Govindarajan United States
Phillip M. Gerk
Citations per year, relative to Phillip M. Gerk Phillip M. Gerk (= 1×) peers Rajgopal Govindarajan

Countries citing papers authored by Phillip M. Gerk

Since Specialization
Citations

This map shows the geographic impact of Phillip M. Gerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip M. Gerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip M. Gerk more than expected).

Fields of papers citing papers by Phillip M. Gerk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip M. Gerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip M. Gerk. The network helps show where Phillip M. Gerk may publish in the future.

Co-authorship network of co-authors of Phillip M. Gerk

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip M. Gerk. A scholar is included among the top collaborators of Phillip M. Gerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip M. Gerk. Phillip M. Gerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lafrenaye, Audrey D., et al.. (2025). In vivo pharmacokinetic evaluation of Veech ketone monoester and metabolites in rats after IV (bolus and infusion) and oral administration. International Journal of Pharmaceutics. 684. 126130–126130.
2.
Gerk, Phillip M., et al.. (2023). Analysis of a major metabolite of ursolic acid— Ursolic acid sulfate, and its quantitative determination on LC/MS in human liver homogenate. Journal of Chromatography B. 1222. 123695–123695. 1 indexed citations
3.
Dozmorov, Mikhail G., Lin Xie, Karolina A. Åberg, et al.. (2020). DNA methylation and histone acetylation changes to cytochrome P450 2E1 regulation in normal aging and impact on rates of drug metabolism in the liver. GeroScience. 42(3). 819–832. 27 indexed citations
4.
Bielski, Elizabeth, et al.. (2020). Megalin-targeting liposomes for placental drug delivery. Journal of Controlled Release. 324. 366–378. 31 indexed citations
5.
Gerk, Phillip M., et al.. (2019). Peroxynitrite and 4-Hydroxynonenal Inactivate Breast Cancer Resistance Protein/ABCG2. BioMed Research International. 2019. 1–6. 2 indexed citations
6.
Zhang, Zhenxian, Yan Zhang, & Phillip M. Gerk. (2018). Preparation of phenylephrine 3-O-sulfate as the major in vivo metabolite of phenylephrine to facilitate its pharmacokinetic and metabolism studies. Journal of Pharmacological and Toxicological Methods. 95. 66–69. 1 indexed citations
7.
Vaidya, Soniya, Marie V. St–Pierre, Andrei M. Mikheev, et al.. (2016). Placental ABC Transporters: Biological Impact and Pharmaceutical Significance. Pharmaceutical Research. 33(12). 2847–2878. 81 indexed citations
8.
Akour, Amal, Mary Jayne Kennedy, & Phillip M. Gerk. (2015). The Role of Megalin in the Transport of Gentamicin Across BeWo Cells, an In Vitro Model of the Human Placenta. The AAPS Journal. 17(5). 1193–1199. 16 indexed citations
9.
Zha, Weibin, Guangji Wang, Weiren Xu, et al.. (2013). Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages. PLoS ONE. 8(1). e54349–e54349. 32 indexed citations
10.
Kohen, Paulina, Soledad Henríquez, Phillip M. Gerk, et al.. (2013). 2-Methoxyestradiol in the human corpus luteum throughout the luteal phase and its influence on lutein cell steroidogenesis and angiogenic activity. Fertility and Sterility. 100(5). 1397–1404.e1. 17 indexed citations
11.
Brophy, Donald F., Erika G. Martin, John C. Barrett, et al.. (2011). Monitoring rFVIIa 90 μg kg−1 dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h. Haemophilia. 17(5). e949–57. 8 indexed citations
12.
Clay, Patrick G., et al.. (2011). Postpartum Pharmacokinetics of Peramivir in the Treatment of 2009 H1N1 Influenza. Obstetrics and Gynecology. 118(2). 463–467. 9 indexed citations
13.
Li, Wenlin, Mark Elliott, Xiaolin Kang, et al.. (2011). Monitoring cellular accumulation of 3′-deoxy-3′-fluorothymidine (FLT) and its monophosphate metabolite (FLT-MP) by LC–MS/MS as a measure of cell proliferation in vitro. Journal of Chromatography B. 879(28). 2963–2970. 5 indexed citations
14.
Vaidya, Soniya, Scott W. Walsh, & Phillip M. Gerk. (2011). Application of Human Placental Villous Tissue Explants to Study ABC Transporter Mediated Efflux of 2,4-Dinitrophenyl-S-Glutathione. Current Pharmaceutical Biotechnology. 12(5). 814–823. 15 indexed citations
15.
Gulati, Abhishek, F. Douglas Boudinot, & Phillip M. Gerk. (2009). Binding of Lopinavir to Human α1-Acid Glycoprotein and Serum Albumin. Drug Metabolism and Disposition. 37(8). 1572–1575. 24 indexed citations
16.
17.
Gerk, Phillip M., et al.. (2006). Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate. Journal of Pharmacology and Experimental Therapeutics. 320(2). 893–899. 26 indexed citations
18.
Gerk, Phillip M., Wěi Li, & Mary Vore. (2004). ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE. Drug Metabolism and Disposition. 32(10). 1139–1145. 25 indexed citations
19.
Gerk, Phillip M., Jeffrey A. Moscow, & Patrick J. McNamara. (2003). BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION. Drug Metabolism and Disposition. 31(6). 691–693. 11 indexed citations
20.
Gerk, Phillip M., Robert J. Kuhn, Nirmala S. Desai, & Patrick J. McNamara. (2001). Active Transport of Nitrofurantoin into Human Milk. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(6). 669–675. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajgopal Govindarajan Breakdown of academic impact, for papers by Justina C. Calamia Breakdown of academic impact, for papers by Dandan Wang Breakdown of academic impact, for papers by Diane R. Umbenhauer Breakdown of academic impact, for papers by Pavol Žúbor Breakdown of academic impact, for papers by Kamil Biringer Breakdown of academic impact, for papers by Leslie J. Dickmann Breakdown of academic impact, for papers by Elodie Jouan Breakdown of academic impact, for papers by María Laura Ruiz Breakdown of academic impact, for papers by Samaisukh Sophasan
Rankless by CCL
2026